City University of New York
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, City University of New York sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
City University of New York: 9 sponsored US clinical trials, 1 recruiting.
City University of New York sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Lactation Disorder - Postpartum Condition or Complication, with 1 trials.
Top-decile sponsor footprint
City University of New York ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
9 total, page 1 of 1
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
NCT04142866
Use of Ritual Epost Postnatal Multivitamins During the Postpartum Period
NCT05736562
Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
NCT05140421
Nutrition Intervention Combined With Resmetirom for MASH
NCT07680478
Use of Ritual Prenatal Multivitamins for Pregnancy
NCT05673070
Assessing Perceptions and Preferences Around Long-acting Injectables (APPLI)
NCT05833542
Transspinal Stimulation Plus Locomotor Training for SCI
NCT04807764
Activity-Dependent Transspinal Stimulation in SCI
NCT03669302
Adaptation and Implementation of Project Encuentro in the U.S.-Mexico Border
NCT03293875
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where City University of New York enrollment is open (later-stage tilt)
1 recruiting of 9 indexed (11% open); 4 completed (44%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Lactation Disorder - Postpartum Condition or Complication (1 trial), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
City University of New York: open-pipeline peers nationwide
Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
City University of New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 trials (± recruiting share)
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
Related
What to do with this City University of New York page
9 registered trials is a research-attention snapshot, not an endorsement of City University of New York or any single study.
- 1 of City University of New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Lactation Disorder - Postpartum Condition or Complication is the condition City University of New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lactation Disorder - Postpartum Condition or Complication trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. City University of New York pipeline card: 9 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.